{
  "id": "Ex006",
  "type": "Example",
  "informationId": {
    "id": "CG-EX:CritAssess280",
    "type": "CriterionAssessment",
    "criterion": {
      "id": "SEPIO-CG:99023",
      "type": "Criterion",
      "label": "PS1",
      "description": "Same amino acid change as a previously established pathogenic variant regardless of nucleotide change",
      "defaultStrength": {
        "id": "SEPIO:0000330",
        "type": "EvidenceLineStrength",
        "label": "Pathogenic Strong"
      },
      "comments": "Beware of changes that impact splicing rather than at the amino acid/protein level\nFrom CSER paper: One site erroneously used this to apply prior publication of the same exact variant while this rule, as described in more depth on the ACMG/AMP guideline, only applies when the established pathogenic variant has a different nucleotide change than the variant being interpreted."
    },
    "variant": {
      "id": "CAR:CA341206",
      "type": "CanonicalAllele",
      "preferredCtxAllele": {
        "id": "CG-EX:CtxAll012",
        "type": "ContextualAllele",
        "relatedCanonicalAllele": "CanAll010",
        "alleleName": "NM_176795.4(HRAS):c.173C>T (p.Thr58Ile)",
        "produces": [
          {
            "id": "CG-EX:CtxAll015",
            "type": "ContextualAllele",
            "relatedCanonicalAllele": "CanAll012",
            "alleleName": "NP_005334.1:p.Thr58Ile",
            "producedBy": "CtxAll012"
          }
        ]
      }
    },
    "condition": [
      {
        "id": "CG-EX:GenCond005",
        "type": "GeneticCondition",
        "disease": [
          {
            "id": "Orphanet:3071",
            "type": "Disease",
            "label": "costello syndrome"
          }
        ],
        "modeOfInheritance": {
          "id": "HP:0000006",
          "type": "ModeOfInheritance",
          "label": "Autosomal Dominant"
        }
      }
    ],
    "outcome": {
      "id": "SEPIO:0000223",
      "type": "CriterionEvaluation",
      "label": "Met"
    },
    "evidenceLine": [
      {
        "id": "CG-EX:EvLn007",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "CG-EX:VarInterp010",
            "type": "VariantInterpretation",
            "variant": {
              "id": "CAR:CA256480",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CG-EX:CtxAll014",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll011",
                "alleleName": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile)",
                "produces": [
                  {
                    "id": "CG-EX:CtxAll016",
                    "type": "ContextualAllele",
                    "relatedCanonicalAllele": "CanAll013",
                    "alleleName": "NP_004976.2:p.Thr58Ile",
                    "producedBy": "CtxAll014"
                  }
                ]
              }
            },
            "condition": [
              {
                "id": "CG-EX:GenCond006",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "OMIM:609942",
                    "type": "Disease",
                    "label": "noonan syndrome 3"
                  }
                ]
              }
            ],
            "outcome": {
              "id": "LN:LA6668-3",
              "type": "Significance",
              "label": "Pathogenic"
            },
            "description": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile) Pathogenic for Noonan Syndrome 3"
          }
        ]
      },
      {
        "id": "CG-EX:EvLn008",
        "type": "EvidenceLine",
        "evidenceItem": [
          {
            "id": "CG-EX:VarInterp011",
            "type": "VariantInterpretation",
            "variant": {
              "id": "CAR:CA256480",
              "type": "CanonicalAllele",
              "preferredCtxAllele": {
                "id": "CG-EX:CtxAll014",
                "type": "ContextualAllele",
                "relatedCanonicalAllele": "CanAll011",
                "alleleName": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile)",
                "produces": [
                  {
                    "id": "CG-EX:CtxAll016",
                    "type": "ContextualAllele",
                    "relatedCanonicalAllele": "CanAll013",
                    "alleleName": "NP_004976.2:p.Thr58Ile",
                    "producedBy": "CtxAll014"
                  }
                ]
              }
            },
            "condition": [
              {
                "id": "CG-EX:GenCond055",
                "type": "GeneticCondition",
                "disease": [
                  {
                    "id": "Orphanet:648",
                    "type": "Disease",
                    "label": "noonan syndrome"
                  }
                ],
                "modeOfInheritance": {
                  "id": "HP:0000006",
                  "type": "ModeOfInheritance",
                  "label": "Autosomal Dominant"
                }
              }
            ],
            "outcome": {
              "id": "LN:LA6668-3",
              "type": "Significance",
              "label": "Pathogenic"
            },
            "description": "NM_004985.4(KRAS):c.173C>T (p.Thr58Ile) Pathogenic for Costello syndrome"
          }
        ]
      }
    ],
    "contribution": [
      {
        "type": "Contribution",
        "agent": {
          "id": "CG-EX:Agent001",
          "type": "Agent",
          "label": "Harry Stevenson"
        },
        "contributionDate": "6/2/16 5:22 PM",
        "contributionRole": {
          "id": "SEPIO:0000154",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      },
      {
        "type": "Contribution",
        "agent": {
          "id": "CG-EX:Agent002",
          "type": "Agent",
          "label": "Noonan/Rasopathy WG (ClinGen)"
        },
        "contributionDate": "6/2/16 5:22 PM",
        "contributionRole": {
          "id": "SEPIO:0000154",
          "type": "ContributoryRole",
          "label": "assessor role"
        }
      }
    ],
    "description": "While the two amino acid changes are not identical, they are the same amino acid change in analagous residues of HRAS and KRAS."
  },
  "index": 3,
  "author": "Steven Harrison",
  "description": "The Noonan WG decided PS1 was applicable for the same analogous residue positions/regions in highly analogous grouping (HRAS/KRAS/NRAS and MAP2K1/MAP2K2).  So HRAS c.173C>T - p.Thr58Ile [g.533883G>A (chr11, GRCh37)] could use KRAS c.173C>T - p.Thr58Ile [g.25380285G>A (chr12, GRCh37)] and vice versa",
  "@context": "http://datamodel.clinicalgenome.org/interpretation/json/context"
}
